September 9, 2020 Comments Off on Patent delisted for Merck Sharp drug PREVYMIS Posted in: Uncategorized
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugP…
September 9, 2020 Comments Off on Patent delisted for Otsuka drug ABILIFY MYCITE KIT Posted in: Uncategorized
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…
The post Patent delisted for Otsuka drug ABILIFY MYCITE KIT appea…